InterVentional Technologies
This article was originally published in The Gray Sheet
Executive Summary
Firm enrolls first of 1,244 patients in a randomized controlled study comparing restenosis rates of its Barath surgical dilatation balloon catheter and conventional percutaneous transluminal coronary angioplasty. The cutting balloon "combines a conventional angioplasty balloon with microsurgical blades" that "incise the lesion ahead of the expanding balloon." Animal studies indicate that the combination will "facilitate maximal dilatation of the artery and lesion with the least amount of dilating force, which minimizes trauma to the artery." The investigational device exemption allows for 20 centers; 15 are expected to "come on line" by the middle of August
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.